IV Chelation
Chelation therapy is an intravenous treatment used to rid the body of potentially
deadly toxins, to restore good circulation to all of the bodily tissues, and
to remove or reduce the amount of debris along the arterial walls. It has been
proven to effectively treat atherosclerosis (hardening of the arteries) and
gangrene, and can dramatically improve the quality of life for patients with
arthritis, lupus, scleroderma, and failing memories. A mildly acidic substance
called ethylenediaminetetraacetic acid (EDTA) is added to the bloodstream to
break down metastatic calcium and mobilize heavy metals for excretion through
the kidneys. A chelation treatment, or infusion, takes between two and three
hours, during which the patient is asked to rest comfortably. The treatments
themselves are painless and there are almost no reported side effects. The number
of treatments required depends on the patient's initial condition and how well
his or her body responds to the infusions.
Since the 1960's, almost one million North Americans have been treated with
chelation therapy, but government regulators have yet to approve the use of
EDTA for anything other than reducing heavy metal toxicity. The amount of EDTA
used in each infusion treatment is said to be less toxic than taking one aspirin
tablet. Some researchers have asserted that if chelation were to be adopted
as a standard medical practice for reducing arterial plaque, nearly 85% of coronary
bypass surgeries could be avoided.
